CCR5 and melanoma: However, when tested in melanoma-bearing mice, maraviroc treatment had limited to no impact on tumor growth, which is consistent with the overall lower levels of CCR5 chemokines present in the tumor bed of B16 melanoma (Supplemental Figure 3E).